Background: Post-stroke cognitive impairment (PSCI) occurs commonly and is linked with development of dementia. We investigated the relationship between demographic, clinical and stroke symptoms at stroke onset and the presence of PSCI at 1 and 3 years after stroke.
(haemorrhagic stroke, left hemisphere stroke, dysphasia, stroke severity and infarct volume), the number of strokes (previous stroke, multiple infarcts and recurrent stroke) and the complications of stroke (incontinence, early seizures, acute confusion, hypoxic ischaemic episodes and hypotension). Others factors included demographic features (older age, low educational attainment, previous cognitive decline and premorbid disability) and vascular risk factors (diabetes and atrial fibrillation). 6 However, there was substantial heterogeneity among the studies in terms of setting, inclusion or exclusion of patients with prestroke dementia, whether only first-ever, any or only recurrent strokes were included, and the method of dementia diagnosis. Moreover, relationship between clinical stroke features of the acute event (i.e. stroke symptoms) and cognitive performance is less well described.
The aim of the present study was to expand the above findings for post-stroke dementia in a large and independent data set and to specifically investigate the associations between demographic, clinical and stroke features and PSCI in patients with recent stroke or transient ischaemic attack.
| METHODS
We conducted a retrospective analysis of individual patient-level data from the Virtual International Stroke Trial Archive (VISTA). VISTA is an academic collaboration which provides access to existing patient trial data to perform exploratory analyses with the aim to help planning and design of future clinical trials. 7 Ethical approval was not required since data were anonymized.
Our study population included patients with first-ever brain vascular event, including ischaemic stroke, haemorrhagic stroke, transient ischaemic attack (TIA). We excluded subarachnoid haemorrhages.
Clinical variables of interest included age, sex, hypertension, diabetes, atrial fibrillation, ischaemic heart disease, hypercholesterolaemia, depression (history of), cigarette smoke exposure. Functional status at baseline was assessed with the Oxford Handicap Scale (OHS). 8 Baseline stroke symptoms included clinical evaluation of arm and leg weakness, sensory deficit, aphasia, neglect, hemianopia dichotomized as presence/absence at stroke onset. All patients underwent global assessment to define stroke subtype, including radiological examinations (CT or MR), extensive blood tests, thoracic and neck vessels imaging and cardiac assessment where appropriate.
Cognitive function among survivals at 1 and 3 years was assessed on voluntary basis using MMSE, defining cognitive impairment as a score of MMSE≤26. 9 We described the characteristics of study population at baseline, 1 and 3 years.
Furthermore, we described the differences in baseline characteristics of patients for whom the MMSE was available and for whom the MMSE was not available, using chi-square for categorical vari- 
| RESULTS
Data at baseline were available for 5453 patients, of whom 3476 (65%) were male, and the mean age (±SD) was 62.5 (±12.5) years.
The median time from the onset of the qualifying event (stroke or TIA) to baseline assessment was 33 days (IQR=8-88).
The qualifying event was ischaemic stroke in 3970 (73%) of patients, TIA in around one-fifth (1022, 19%) and haemorrhagic stroke in 461 (8%). Assessment of cognitive status at baseline was not available for 540 (10%) patients, whereas 29 (0.5%) had clinical diagnosis of dementia and were therefore excluded from the analysis. Table 1 shows baseline characteristics of study population. The majority of patients were functionally independent, with a median OHS of 1 (IQR=1-2). Hypertension was the most frequent cardiovascular risk factor (71%). About two-thirds of patients had either arm or leg paralysis, whereas cortical symptoms such as neglect were less frequent (8%).
After 1 year, 129 (2.4%) of patients died, and after 3 years, a total of 323 (5.9%) had died. At 1 and 3 years, follow-up data on MMSE were available for 2270 (41.6%) and 1294 (23.7%) patients, respectively.
Patients for whom MMSE scores were available were older (P<.001 at 1 and 3 years) and more likely to have less disability at baseline (P<.001 at 1 and 3 years). They also had fewer neurological impair- functional status at baseline (P=.028) (Table S3) . Neglect, hemianopia and sensory impairment were not associated with cognitive impairment at one and 3 years in both stroke groups.
| DISCUSSION
We investigated the associations between baseline stroke symptoms and PSCI defined as MMSE≤26. As defined by this cut-off, in our cohort around one-third of patients with stroke in the long term had cognitive impairment. Age, female sex, stroke severity and history of diabetes were associated with PSCI at one and 3 years and in all study groups. Among stroke symptoms, paralysis in the lower limb at baseline was consistently associated with PSCI.
Our results regarding age, female sex and diabetes are in keeping with previous studies 4, 6 that demonstrated an increased risk of cognitive deficits after stroke. We found that hypertension was associated with PSCI only after 3 years and in the ischaemic stroke subgroup, suggesting a weak association. This result is in line with the aforementioned Pendlebury and Rothwell metanalysis, 6 which showed no association between hypertension and post-stroke dementia.
Interestingly, we found that leg paralysis at baseline appeared to be independently associated with cognitive impairment at both follow-up time points. In addition, we observed a lack of interaction between leg paralysis and functional status at baseline. Gait problems may independently predict disability or death, 10 and risk of both cognitive impairment and dementia. 11, 12 In a population cohort study, hemiparetic gait has been associated with both vascular and non-vascular dementia. 12 A recent prospective study found that gait impairment after mild stroke increased the risk of developing cognitive decline after 2 years. 13 Assuming leg paralysis as a surrogate of gait dysfunction, our results are in keeping with such association and may support the link between leg dysfunction and cognitive impairment.
In our study, aphasia increased the risk of cognitive impairment 1 year after ischaemic stroke/TIA, although associations at 3 years were confounded by interaction with functional status at baseline. We acknowledge that aphasia could negatively affect the assessment of cognitive status with MMSE, which relies on the language ability of the patient. 14 Since language is a cognitive domain, language deficits represent a subset of cognitive impairment; therefore, this result needs to be interpreted with caution.
We acknowledge shortcomings that may have biased our results.
First, our data belong from a study population selected for clinical trials, it seems plausible a selection bias, and our results may not be entirely generalizable. Despite we had not access to a cognitive evaluation at baseline (i.e. evaluation of cognition during the acute stroke phase), which has been associated with PSCI, 15 around 90% of our included patients had clinical evaluation regarding the presence of dementia, and only a little percentage of them had clinical diagnosis of dementia. Again, the non-systematic assessment of cognitive function at follow-up may have lead to an attrition bias. Although we found low mortality rates, our supplemental tables showed that selection likely favoured those with less neurological impairment. The higher rates of baseline symptoms such as paralysis or aphasia in patients without cognitive assessment at follow-up seem to confirm that an attrition bias occurred. However, this fact may have underestimated rather than overestimate our results, reducing the rate of patients with cognitive impairment.
16
Moreover, diagnosis of PSCI should be based on a comprehensive evaluation including a complete multidomain neuropsychological T A B L E 3 Associations between baseline stroke symptoms and cognitive impairment (MMSE≤26) in ischaemic events (ischaemic stroke and TIA). Analysis adjusted for all the variables listed in the Together with attrition bias, it seems likely that the prevalence of cognitive impairment after stroke is higher than we reported. The major strength of our study is that our large sample size considerably increases the world database, providing new data to perform future analysis. Our data are extracted from clinical trial data sets, which likely have less heterogeneity compared to prospective studies and clinical series. The aforementioned meta-analysis investigated 7511 patients with pooled data from a wide range of studies, and our study provides a pool of 5453 patients enrolled in randomized clinical trials.
In conclusion, in our sample of patients with mild stroke, around 30%-34% of patients experienced cognitive impairment between 1 and 3 years. We confirmed increasing age, female sex, stroke severity, history of diabetes as factors associated with PSCI. Among stroke features, leg paralysis may be involved in subsequent cognitive impairment in the long-term follow-up, suggesting that early detection of mobility impairment after stroke may help to identify patients at risk of cognitive impairment.
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